Form D · Biotechnology
Harpoon Therapeutics, Inc.
South San Francisco, CA · CIK 0001708493
Offering snapshot reported Oct 31, 2023 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2023 | Initial | $100,162,467 | No comparison | 18 | SEC filing |
| Apr 7, 2023 | Initial | $25,000,000 | No comparison | 6 | SEC filing |
| Nov 26, 2018 | Initial | $69,999,993 | No comparison | 17 | SEC filing |
| Jun 6, 2017 | Initial | $25,185,208 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $6.38M
- Finders' fees
- $0
- Form D file number
- 021-496040
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cowen and Company, LLC | 7616 | |
| Canaccord Genuity LLC | 1020 | |
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Oct 31, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick Baeuerle | Director |
| Joseph Bailes | Director |
| Pablo Cagnoni | Director |
| Mark Chin | Director |
| Alan Colowick | Director |
| Jonathan Drachman | Director |
| Julie Eastland | Director, Executive |
| Georgia L. Erbez | Executive |
| Luke Evnin | Director |
| Dan Hicklin | Director |
| Ronald Hunt | Director |
| Ron Hunt | Director |
| Gerald Mc Mahon | Director, Executive |
| Scott Myers | Director |
| William E. Picht | Executive |
| Andrew Robbins | Director |
| Natalie R. Sacks | Executive |
| Lauren Silvernail | Director |
| Joanne Viney | Director |
| Luke Walker | Executive |
| Holger Wesche | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
611 Gateway Boulevard, Suite 400
South San Francisco, CA, 94080
South San Francisco, CA, 94080